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Abstract The enzyme nicotinamide mononucleotide (NMN)
adenylyltransferase (EC 2.7.7.1) catalyzes the transfer of the
adenylyl moiety of ATP to NMN to form NAD. A new
purification procedure for NMN adenylyltransferase from
Saccharomyces cerevisiae provided sufficient amounts of enzyme
for tryptic fragmentation. Through data-base search a full
matching was found between the sequence of tryptic fragments
and the sequence of a hypothetical protein encoded by the S.
cerevisiae YLR328W open reading frame (GenBank accession
number U20618). The YLR328W gene was isolated, cloned into
a T7-based vector and successfully expressed in Escherichia coli
BL21 cells, yielding a high level of NMN adenylyltransferase
activity. The purification of recombinant protein, by a two-step
chromatographic procedure, resulted in a single polypeptide of 48
kDa under SDS-PAGE, in agreement with the molecular mass of
the hypothetical protein encoded by YLR328W ORF. The
N-terminal sequence of the purified recombinant NMN adenyl-
yltransferase exactly corresponds to the predicted sequence.
Molecular and kinetic properties of recombinant NMN adenyl-
yltransferase are reported and compared with those already
known for the enzyme obtained from different sources.
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1. Introduction
Besides its fundamental function as a coenzyme in redox
reactions, NAD may also serve as a precursor for molecules
involved in regulatory processes. Indeed, the ADP-ribose moi-
ety of NAD may be transferred to proteins, thus severely
in£uencing their functional state [1]. More recently, it was
discovered that NAD glycohydrolases are able to synthesize
cyclic ADP-ribose, a compound which exerts Ca2-mobilizing
activity [2]. Therefore, in recent years the enzymes involved in
NAD cleavage have gathered increasing interest, while no
comparable e¡ort appears to have been devoted to the study
of the biosynthetic routes leading to NAD formation. In both
de novo and salvage synthesis of nicotinamide nucleotides, a
central role is played by the nuclear enzyme nicotinamide
mononucleotide (NMN) adenylyltransferase, which catalyzes
the formation of NAD (or deamido-NAD) from the mono-
nucleotide and ATP, with the concomitant release of pyro-
phosphate. For the ¢rst time observed and partially kinetically
characterized in yeast autolysate by Kornberg [3], this enzy-
matic activity appears to be of substantial importance, as
shown by its correlation with crucial cellular events, like mi-
tosis and DNA synthesis [4^6]. NMN adenylyltransferase,
which in prokaryotes is critical for cell survival, is very low
in tumor cells, thereby representing a potential target for che-
motherapy [5,7,8]. More recently, the involvement of NMN
adenylyltransferase in the cellular metabolism of potent anti-
tumor agents, like tiazofurin, selenazofurin and benzamide
riboside, has also been demonstrated [9^11].
The ¢rst homogeneous enzymatic preparation of NMN ad-
enylyltransferase has been obtained from the yeast Saccharo-
myces cerevisiae [12]; later NMN adenylyltransferase has been
puri¢ed to homogeneity also from human placenta, bull testis,
and thermophilic bacteria [13^15].
The level of eukaryotic NMN adenylyltransferase is low in
most tissues and the puri¢ed enzyme is very unstable. A re-
combinant enzyme source is therefore needed for the study of
its structure and function.
In our laboratory we have identi¢ed, cloned and expressed
the gene for NMN adenylyltransferase from the thermophilic
archaeon Methanococcus jannaschii, which to date is the only
known gene for this enzyme [15]. In addition we have recently
demonstrated that Synechocystis sp. slr0787 protein is a novel
bifunctional enzyme endowed with both nicotinamide mono-
nucleotide adenylyltransferase and ‘Nudix’ hydrolase activities
[16].
Determination of the sequence of NMN adenylyltransferase
tryptic fragments allowed us to identify the YLR328 open
reading frame (ORF) from the S. cerevisiae genome sequence
as the NMN adenylyltransferase gene. In this paper, we report
on the ¢rst identi¢cation, cloning and expression of a eukary-
otic NMN adenylyltransferase gene, the major molecular and
kinetic properties of the recombinant protein are also de-
scribed. A preliminary version of this paper has been pub-
lished in abstract form as an adjunct to a meeting [17].
2. Materials and methods
2.1. Materials
Phage clone of S. cerevisiae DNA segment (lambda PM-2035) (No.
70036), containing the YLR328 gene, was purchased from the Amer-
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ican Type Culture Collection (Rockville, MD). Oligonucleotide pri-
mers were obtained from Life Technologies (Milan, Italy). Restriction
enzymes were obtained from Promega Biotec (Madison, WI), and T4
DNA ligase, PCR reagents, and enzymes were obtained from Boeh-
ringer Mannheim GmbH. The basic molecular biology procedures for
bacterial growth, plasmid DNA puri¢cation, and preparation and
transformation of competent cells as described by Sambrook et al.
[18] were followed.
2.2. Sequencing of S. cerevisiae NMN adenylyltransferase proteolytic
fragments
The original enzyme puri¢cation procedure [12] has been revised.
Brie£y, the steps were as follows: crude extract from yeast; pH 5.0
precipitation; heat treatment; hydroxyapatite chromatography; dye-
ligand chromatography on Matrex Green A; FPLC on phenyl Super-
ose HR 5/5. The ¢nal SDS-PAGE [10% (w/v) gel] was performed by
the method of Schagger and von Jagow [19]. After Coomassie brilliant
blue staining the band corresponding to NMN adenylyltransferase
was excised and subjected in situ to tryptic digestion. The fragments
generated were separated by reverse-phase liquid chromatography on
a ABI 173 A Capillary LC/Microblotter System and sequenced by
using an Applied Biosystems Procise Model 491 sequencer.
2.3. Cloning of the YRL328 gene
The synthetic oligonucleotide primers 5P-ACA GTC GAC ATG
GAT CCC ACA AGA GCT CCG-3P and 5P-CTA AAG CTT TCA
TTC TTT GTT TCC AAG AAC-3P were used in a PCR to amplify
the YLR328 ORF and to insert the SalI and HindIII restriction sites
at its 5P and 3P ends, respectively. PCR was performed with 8 ng of
S. cerevisiae DNA segment (lambda PM-2035) as the template, with
20 pmol of each primer in a ¢nal volume of 100 Wl. Each cycle was set
for 1 min of denaturation at 95‡C, 1 min of annealing at 42‡C, and
1 min of elongation at 72‡C, and 30 reaction cycles were carried out
in a DNA thermal cycler. The ampli¢ed DNA contained a 1.2 kb
product visible by ethidium bromide staining, after electrophoresis
in a 1% agarose gel. The product was digested with SalI and HindIII,
and cloned into SalI-HindIII-digested pT7-7 plasmid vector [20] to
obtain the construct pT7-7-YLR328. The nucleotide sequence of the
insert was con¢rmed by direct sequencing, to ascertain that no muta-
tions had been introduced during the ampli¢cation reaction. The con-
struct was used to transform Escherichia coli TOP10 (Invitrogen) for
plasmid preparation and E. coli BL21 (DE3) for protein expression.
2.4. Puri¢cation of the YLR328 ORF-encoded protein
2.4.1. Growth and expression. Single colonies of strain BL21
(DE3) harboring the pT7-7-YLR328 plasmid were inoculated into
50 ml of Luria-Bertani medium (supplemented with ampicillin at
100 Wg/ml) and grown at 37‡C to an A600 of 0.700. A 10 ml portion
was used to inoculate 1 liter of fresh Luria-Bertani medium (supple-
mented with ampicillin at 100 Wg/ml), and the mixture was incubated
overnight at 120 rpm at 37‡C. The culture was then induced with
1 mM IPTG. Incubation was continued for 5 h at 37‡C with shaking
before the cells were harvested by centrifugation (10 000Ug for 10 min
at 4‡C), and either carried on for puri¢cation or stored at 380‡C.
2.4.2. Crude extract. All steps were performed at 4‡C. The cell
pellet was suspended in 50 ml of 50 mM Tris-HCl pH 8.0, containing
1 mM DTT and disrupted by sonication. The lysate was centrifuged
at 15 000Ug for 30 min (crude extract).
2.4.3. Heat treatment. The crude extract was heated to 60‡C for
10 min, and centrifuged at 16 000Ug for 30 min. The resulting super-
natant is referred to as the 60‡C fraction.
2.4.4. Matrex Gel Green A chromatography. The 60‡C fraction
was applied to a Matrex Gel Green A dye-ligand chromatography
column, previously equilibrated with 20 mM Tris-HCl pH 8.0, con-
taining 1 mM DTT. The column was washed with the same bu¡er,
containing 1 M NaCl and then eluted with a linear gradient of 1^3 M
NaCl in the equilibration bu¡er (Green A fraction).
2.4.5. FPLC on phenyl Superose HR 5/5. The Green A fraction
was made 3 M in NaCl and injected in 1 ml aliquots into a phenyl
Superose HR 5/5 FPLC column, previously equilibrated with 20 mM
Tris-HCl pH 8.0, containing 1 mM DTT and 3 M NaCl. The column
was washed with the same bu¡er and eluted with a discontinuous
gradient from 3 to 0 M NaCl in 20 mM Tris-HCl pH 8.0, containing
1 mM DTT. Active fractions were pooled, concentrated by ultra¢ltra-
tion and stored at 4‡C (phenyl Superose fraction).
2.5. NMN adenylyltransferase assay and kinetic characterization
Enzyme activity was routinely measured by a continuous spectro-
photometric coupled enzyme assay [21]. In an alternative assay pro-
cedure, the enzyme activity was calculated by HPLC [21]. The optimal
reaction conditions were established by varying both the divalent
cation concentration and the pH of the reaction bu¡er, using
30 mM BisTris-HCl and 30 mM Tris-HCl adjusted to the desired
pH (5.0^9.0). One enzyme unit is de¢ned as the amount of enzyme
that catalyzes the formation of 1 Wmol of NAD per minute at
37‡C.
2.6. Other determinations
Gel electrophoresis of the recombinant S. cerevisiae NMN adenyl-
yltransferase was carried out according to the method of Schagger
and von Jagow in 10% polyacrylamide gel [19]. Gel ¢ltration of re-
combinant S. cerevisiae NMN adenylyltransferase was performed by
FPLC with a Superose 12 HR 10/30 (Pharmacia) column equilibrated
with 50 mM sodium phosphate bu¡er, pH 7.0, containing 0.5 M NaCl
and 1 mM DTT.
N-terminal sequence analysis of recombinant S. cerevisiae NMN
adenylyltransferase spotted on a polyvinylidene di£uoride membrane
was performed by automated Edman degradation as above described.
Protein concentration was determined by the method of Bradford
[22].
3. Results and discussion
3.1. Identi¢cation, cloning, and expression of S. cerevisiae
NMN adenylyltransferase gene
When examined after SDS-PAGE, the puri¢ed enzyme
(phenyl Superose fraction) showed a Coomassie-stained major
band of approx. 46 000, in good agreement with the molecular
mass of S. cerevisiae NMN adenylyltransferase. Attempts to
determine the NH2-terminal sequence of the protein failed,
presumably because of the presence of a modi¢ed amino
acid residue at the NH2-terminus. Therefore, the protein mi-
grating at 46 000 was excised, digested with trypsin, and the
resulting peptides were separated and sequenced, as described
in Section 2.
A search of the S. cerevisiae genome sequence database,
with the BLAST [23] network service at the National Center
for Biotechnology Information, revealed that two peptides,
DLEEVPHGIVR and VLDHFNHEIN, were identical to res-
idues 129^139 and 256^265 encoded by the YLR328w gene,
located on chromosome XII. In addition, the molecular mass
of 45.9 kDa predicted for the polypeptide encoded by the
YLR328w ORF closely corresponds to the subunit molecular
mass obtained for the S. cerevisiae enzyme. To con¢rm that
the YLR328w ORF indeed encodes NMN adenylyltransfer-
ase, the gene was isolated and cloned into a T7-based vec-
tor.
E. coli BL21(DE3) cells harboring the recombinant plasmid
were grown, induced with IPTG, and extracted as described in
Section 2. Cell extracts were assayed for NMN adenylyltrans-
ferase activity. Even in the absence of added IPTG, a high
level of NMN adenylyltransferase activity could be detected in
BL21 cells transformed with the recombinant plasmid, while
BL21(DE3) containing the expression vector alone had no
detectable NMN adenylyltransferase activity. A two-fold
greater NMN adenylyltransferase total activity was obtained
5 h after induction with IPTG. In the crude extract of
BL21(DE3) cells transformed with the recombinant plasmid,
upon SDS-PAGE, the presence of a polypeptide of the ex-
pected size was evidenced, whereas it was absent in crude
extract of bacteria lacking the YLR328w coding sequence
(data not shown).
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3.2. Puri¢cation and properties of recombinant S. cerevisiae
NMN adenylyltransferase
Recombinant NMN adenylyltransferase was puri¢ed 58-
fold to homogeneity in two chromatographic steps, as de-
scribed in Section 2 (Table 1). Dye-ligand chromatography
on Matrex Gel Green A was successful in removing most of
the contaminating proteins, the recombinant NMN adenylyl-
transferase being by far the most abundant component in the
column eluate (Fig. 1). The ¢nal FPLC on phenyl Superose
HR 5/5 was able to yield an enzymatic preparation, with a
speci¢c activity of 74.2 U/mg. By means of this puri¢cation
procedure a yield of approx. 0.9 mg of pure recombinant
NMN adenylyltransferase per liter of culture was obtained.
SDS-PAGE analysis indicated that the puri¢ed recombinant
protein had a molecular mass of 48 kDa, which corresponds
with the molecular mass predicted for the amino acid se-
quence (Fig. 1). The native molecular mass of the active re-
combinant enzyme was determined to be 195 kDa by gel
¢ltration, suggesting that it is an oligomer composed of four
identical subunits, as previously observed for the wild type
enzyme [12].
Identi¢cation of the 48 kDa protein as that encoded by the
cloned YLR328 gene was performed by N-terminal amino
acid sequencing of pure recombinant protein. Sequencing of
the ¢rst 22 amino acid residues yielded an exact match with
the predicted sequence.
The recombinant NMN adenylyltransferase has an absolute
requirement for divalent cations, achieving optimal activity
with 5 mM Ni2 ; various heavy metal ions markedly depress
the enzyme activity, the most e¡ective being Hg2, completely
abolishing NMN adenylyltransferase activity when present in
the assay mixture at a concentration of 0.05 mM, similar to
what previously reported for human NMN adenylyltransfer-
ase [14]. In contrast to pig liver NMN adenylyltransferase,
which utilizes various purine nucleoside triphosphates [24],
the recombinant NMN adenylyltransferase seems to be spe-
ci¢c for adenylic nucleoside triphosphates, no activity being
detected in the presence of ITP and GTP. The optimum pH is
identical to the wild type enzyme [12].
3.3. Structural analysis of recombinant S. cerevisiae NMN
adenylyltransferase
The hydrophobicity pro¢le, performed according to Kyte
and Doolittle [25] (Fig. 2), suggests the existence of several
hydrophobic fragments likely corresponding to transmem-
brane regions. Another distinctive feature is the existence, at
the NH2-terminal region, of a hydrophilic segment, which
involves a cluster of histidines (amino acids 61^67), which
should represent a potential metal binding site.
It is interesting that the consensus sequences both for dinu-
cleotide binding proteins and for mononucleotide binding
proteins, as proposed by Moller and Amons [26], are not
present in the recombinant protein sequence. Using the
MOTIFS program, we identi¢ed in recombinant S. cere-
visiae NMN adenylyltransferase the consensus motif
p..[de].y.[ekq].g[¢lvy], which represents a feature of many ad-
Table 1
Puri¢cation of recombinant S. cerevisiae NMN adenylyltransferasea
Fraction Total protein (mg) Total activity (U) Sp. act. (U/mg) % Yield Puri¢cation factor
Extract 121 154 1.27 100 ^
60‡C fraction 100 178 1.78 116 1.4
Green A 2.35 126 53.6 82 42
Phenyl Superose 0.86 63.8 74.2 41 58
aThe puri¢cation procedure and the enzyme assay were performed as described in Section 2.
Fig. 1. Expression and puri¢cation of recombinant S. cerevisiae
NMN adenylyltransferase. A polyacrylamide gel (10%) containing
0.1% SDS was stained with Coomassie blue. Lane 1 contains refer-
ence proteins; lanes 2, 3, and 4 contain 10 Wg of crude extract, heat
treatment fraction, and Green A fraction, respectively. Lane 5 con-
tains 5 Wg of the puri¢ed recombinant NMN adenylyltransferase.
Fig. 2. Hydrophobicity pro¢le of recombinant S. cerevisiae NMN
adenylyltransferase. The protein was analyzed using the method of
Kyte and Doolittle [25]. The hydropathicity value of each amino
acid residue is plotted against its position in the polypeptide (x
axis), starting with the amino-terminus.
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enylate kinases family members. The signi¢cance of this seg-
ment, starting at amino acid 206, is at present unknown.
Comparison of the amino acid sequences of the three NMN
adenylyltransferases to date known shows that S. cerevisiae
NMN adenylyltransferase is quite di¡erent from the others.
The M. jannaschii NMN adenylyltransferase displays 41%
identity and 60% similarity with the ¢rst 65 residues at the
N-terminus of the Synechocystis sp. NMN adenylyltransferase
[15], while no signi¢cant similarity was found with respect to
S. cerevisiae NMN adenylyltransferase. When we searched the
SwissProt data base we found an ORF, designated
YGR010w, which encodes a putative protein with 395 amino
acids, showing 72% amino acid identity to the S. cerevisiae
NMN adenylyltransferase (Fig. 3). The ORF YGR010w is
located on chromosome VII and might represent a duplica-
tion of NMN adenylyltransferase gene, even though, at
present, no additional experimental data substantiate this
hypothesis.
A Yeast-Worm ClustalW alignment revealed also that S.
cerevisiae NMN adenylyltransferase displays a high degree
of amino acid sequence homology with two hypothetical pro-
teins of Caenorhabditis elegans, designated F26H9.4 and
WO6B3.1. The similarity was 52 and 50%, respectively, thus
suggesting that the two unknown proteins probably possess
NMN adenylyltransferase activity (Fig. 3). Therefore, from an
evolutionary perspective it appears that the NMN adenylyl-
transferase gene into the diverging branches of the eukaryotic
subtree has retained common features, while it has arrived at
separate solutions with respect to its prokaryotic counterpart.
Although the enzyme NMN adenylyltransferase has been
studied for a long time, its regulation and mechanism are still
poorly understood. Cloning of NMN adenylyltransferase gene
from a eukaryotic organism and availability of large amounts
of recombinant enzyme will be instrumental both for studying
its expression in di¡erent cells and organs and for undertaking
more detailed structural studies of the enzymatic protein.
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